Search

Your search keyword '"Baldari S."' showing total 15 results

Search Constraints

Start Over You searched for: Author "Baldari S." Remove constraint Author: "Baldari S." Publisher elsevier bv Remove constraint Publisher: elsevier bv
15 results on '"Baldari S."'

Search Results

1. 1394P Alkaline phosphatase (ALP) decline and pain response as markers for overall survival (OS) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (223Ra) in the REASSURE study

7. Use of bone health agents (BHAs) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) after abiraterone (Abi): An interim review of REASSURE

8. Tumour growth rate (TGR) when using lanreotide Autogel® (LAN) before, during and after peptide receptor radionuclide therapy (PRRT) in advanced neuroendocrine tumours (NETs)

9. REASSURE observational study of radium-223 (Ra-223): First interim results by prior/concomitant treatment (Tx) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) enrolled in Europe

10. Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP)

11. Patient (pt) characteristics and treatment patterns in the radium (Ra)-223 REASSURE observational study

12. Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP)

13. Analysis of overall survival by number of radium-223 injections received in an international expanded access program (iEAP)

14. 1408 POSTER DISCUSSION The Role of 2deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography and Maximum Standardized Uptake Value in Predicting Prognosis of Patients With Non-Small Cell Lung Cancer in Different Stages (l-IV)

Catalog

Books, media, physical & digital resources